The initial public offering (IPO) of Gujarat Kidney & Super Speciality Limited has witnessed a strong reception from the investment community as it enters its second day of bidding. The public issue, which opened for subscription on Monday, December 22, 2025, has already been oversubscribed, reflecting significant investor confidence in the healthcare provider's prospects.
Robust Subscription Numbers on Day 2
According to data available, the IPO has been booked approximately 1.5 times so far, building on the momentum from the first day. On the opening day itself, the issue received a powerful response, garnering an overall subscription of 1.53 times. This indicates a steady and healthy inflow of applications from various investor categories, including retail individuals, high-net-worth individuals, and institutional players.
Company Profile and Financial Health
Gujarat Kidney and Super Speciality is a prominent healthcare service provider operating in central Gujarat. The company manages a network of seven mid-sized multi-speciality hospitals, specializing in both secondary and tertiary care. Its current operational capacity stands at a total of 490 beds across its facilities.
The company's financial performance underscores its stable footing. For the financial year that ended in March 2025, Gujarat Kidney reported a revenue from operations of ₹40.24 crore. More impressively, it achieved a net profit of ₹9.5 crore during the same period, highlighting its profitability in a competitive sector.
Should You Apply? Key Considerations for Investors
The decision to apply for an IPO requires careful evaluation. Prospective investors are closely monitoring the Grey Market Premium (GMP) as an informal indicator of listing day sentiment. While the strong subscription figures point towards healthy demand, experts advise a thorough review of the company's fundamentals, its growth strategy in the healthcare space, and the valuation at which the shares are being offered.
Key factors to consider include the company's established presence in its regional market, its consistent profitability, and the long-term growth potential of the healthcare industry in India. However, like all market-linked instruments, IPOs carry inherent risks, and past performance is not a guarantee of future results.
Disclaimer: This news article is for informational and educational purposes only. The views and recommendations mentioned are not those of the publisher. Investors are strongly advised to consult with SEBI-certified financial experts and advisors before making any investment decisions.
